Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer

被引:0
|
作者
Lin, Jessica Jiyeong
Tan, Daniel Shao-Weng
Kummar, Shivaani
Patel, Jyoti D.
Cermignani, Luciano
Dai, Ming-Shen
Lassen, Ulrik Niels
Leyvraz, Serge
Liu, Yongmei
Moreno, Victor
Rosen, Lee S.
Saada-Bouzid, Esma
Solomon, Benjamin Maurice
Xu, Rui-Hua
Yachnin, Jeffrey
Norenberg, Ricarda
Burcoveanu, Domnita-Ileana
Mussi, Chiara E.
Shen, Lin
Drilon, Alexander E.
机构
[1] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[2] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore
[3] Duke NUS Med Sch, Singapore, Singapore
[4] Oregon Hlth & Sci Univ, Portland, OR USA
[5] Northwestern Univ, Chicago, IL USA
[6] Hosp Aleman, Buenos Aires, Argentina
[7] Tri Serv Gen Hosp, Taipei, Taiwan
[8] Rigshosp, Dept Oncol, Copenhagen, Denmark
[9] Charite Univ Med Berlin, Berlin, Germany
[10] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Peoples R China
[11] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China
[12] START MADRID FJD, Hosp Fdn Jimenez Diaz, Madrid, Spain
[13] UCLA, Div Hematol Oncol, Santa Monica, CA USA
[14] Univ Cote Dazur, Ctr Antoine Lacassagne, Nice, France
[15] Avera Canc Inst, Sioux Falls, SD USA
[16] Sun Yat Sen Univ, State Key Lab, Canc Ctr, Guangzhou, Peoples R China
[17] Karolinska Univ Hosp, Stockholm, Sweden
[18] Chrestos Concept GmbH & Co KG, Essen, Germany
[19] Bayer Healthcare Pharmaceut Inc, Basel, Switzerland
[20] Bayer SpA, Milan, Italy
[21] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Minist Educ Beijing,Canc Hosp & Inst, Beijing, Peoples R China
[22] Mem Sloan Kettering Canc Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9056
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Long-term control and safety of larotrectinib in a cohort of adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors.
    Perreault, Ebastien
    Drilon, Alexander E.
    Lassen, Ulrik Niels
    Geoerger, Birgit
    Nysom, Karsten
    Ora, Ingrid
    Gavrilovic, Igor T.
    Norenberg, Ricarda
    Fellous, Marc Mardoche
    De la Cuesta, Esther A.
    Laetsch, Theodore Willis
    Doz, Francois
    Van Tilburg, Cornelis Martinus
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS
    Perreault, Sebastien
    Doz, Francois
    Geoerger, Birgit
    Italiano, Antoine
    Lassen, Ulrik
    Nilsson, Anna
    Nysom, Karsten
    Spano, Jean-Philippine
    Norenberg, Ricarda
    Bernard-Gauthier, Vadim
    de la Cuesta, Esther
    Drilon, Alexander
    Laetsch, Theodore
    van Tilburg, Cornelis
    NEURO-ONCOLOGY, 2023, 25
  • [43] EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET
    Perreault, Sebastien
    Doz, Francois
    Drilon, Alexander
    Geoerger, Birgit
    Boni, Valentina
    Chisholm, Julia
    Dubois, Steven G.
    Grilley-Olson, Juneko E.
    Hong, David S.
    Italiano, Antoine
    Kang, HyoungJin
    Nysom, Karsten
    Ora, Ingrid
    Owens, Cormac
    Schulte, Johannes H.
    Tahara, Makoto
    Ziegler, David
    Ellezam, Benjamin
    Reeves, John A.
    Fellous, Marc
    De La Cuesta, Esther
    Laetsch, Theodore W.
    van Tilburg, Cornelis M.
    NEURO-ONCOLOGY, 2020, 22 : 58 - 58
  • [44] Long-term outcomes of patients with TRK fusion cancer treated with larotrectinib.
    Drilon, Alexander
    Kummar, Shivaani
    Albert, Catherine M.
    Nagasubramanian, Ramamoorthy
    Hechtman, Jaclyn F.
    Reeves, John A.
    Beckmann, Georg
    Rudolph, Marion
    Wierzbinska, Justyna A.
    Dima, Laura
    Brega, Nicoletta
    Laetsch, Theodore W.
    Hong, David S.
    CANCER RESEARCH, 2021, 81 (13)
  • [45] Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase fusion-positive gastrointestinal cancer: An expanded dataset
    Boni, V.
    Drilon, A.
    Deeken, J.
    Garralda, E.
    Chung, H.
    Kinoshita, I.
    Oh, D.
    Patel, J.
    Xu, R.
    Norenberg, R.
    Brega, N.
    Dima, L.
    Hong, D.
    Berlin, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S214 - S215
  • [46] ACTIVITY OF LAROTRECTINIB IN TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES
    Patel, Jyoti D.
    Farago, Anna F.
    Hong, David S.
    Lassen, Ulrik N.
    Leyvraz, Serge
    Park, Keunchil
    Sohal, Davendra P. S.
    Solomon, Benjamin
    Reeves, John A.
    Dima, Laura
    Brega, Nicoletta
    Drilon, Alexander
    NEURO-ONCOLOGY, 2020, 22 : 41 - 42
  • [47] Larotrectinib efficacy and safety in adult TRK fusion cancer patients.
    Hong, David S.
    Kummar, Shivaani
    Farago, Anna F.
    Lassen, Ulrik Niels
    Berlin, Jordan
    Schilder, Russell J.
    McDermott, Raymond S.
    Patel, Jyoti D.
    Dowlati, Afshin
    Doebele, Robert Charles
    Tan, Daniel Shao-Weng
    Lee, James J.
    Nanda, Shivani
    Childs, Barrett H.
    Ku, Nora
    Drilon, Alexander E.
    Hyman, David Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Larotrectinib efficacy and safety in pediatric TRK fusion cancer patients.
    van Tilburg, Cornelis Martinus
    DuBois, Steven G.
    Albert, Catherine Michelle
    Federman, Noah
    Nagasubramanian, Ramamoorthy
    Geoerger, Birgit
    Orbach, Daniel
    Bielack, Stefan S.
    Shukla, Neerav Narendra
    Turpin, Brian
    Casanova, Michela
    Spunt, Sheri L.
    Qamoos, Hope
    Nanda, Shivani
    Childs, Barrett H.
    Cox, Michael Craig
    Pappo, Alberto S.
    Laetsch, Theodore Willis
    Mascarenhas, Leo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Updated Efficacy, Safety, and Biomarker Analysis in Patients with TRK Fusion Lung Cancer Treated with Larotrectinib
    Lin, J. J.
    Tan, D. S. W.
    Kummar, S.
    Moreno, V.
    Leyvraz, S.
    Dubashi, B.
    Parambath, H.
    Burcoveanu, D. -I.
    Neu, N.
    Leserer, S.
    Seidel, H.
    Mussi, C. E.
    Shen, L.
    Drilon, A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S77 - S77
  • [50] Extended Follow-up of Efficacy and Safety of Larotrectinib in Patients With TRK Fusion Lung Cancer
    Moreno, V.
    Lin, J. J.
    Tan, D. S. W.
    Kummar, S.
    Dai, M. -S.
    Lassen, U. N.
    Leyvraz, S.
    Liu, Y.
    Patel, J. D.
    Rosen, L.
    Solomon, B.
    Yachnin, J.
    Norenberg, R.
    Fellous, M.
    Mussi, C. E.
    Shen, L.
    Drilon, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S473 - S474